Craft

AtriCure

Stock Price

$29

2024-09-23

Market Capitalization

$1.4 B

2024-09-23

Revenue

$399.2 M

FY, 2023

AtriCure Summary

Company Summary

Overview
AtriCure is a medical device company providing atrial fibrillation solutions. It offers an Isolator Synergy ablation system, a medical device for the treatment of persistent Afib; AtriClip, left atrial appendage exclusion system products; Hybrid AF therapy, a procedure that provides a solution for Afib patients; cryoICE and Cryosphere, a probe to block pain, providing pain relief in cardiac and thoracic procedures; and other solutions.
Type
Public
Status
Active
Founded
2000
HQ
Mason, OH, US | view all locations
Website
https://www.atricure.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Michael H. Carrel

    Michael H. Carrel, President, Chief Executive Officer, and Director

  • Angela L. Wirick

    Angela L. Wirick, Chief Financial Officer

  • Justin Noznesky

    Justin Noznesky, Chief Marketing and Strategy Officer

  • Karl Dahlquist

    Karl Dahlquist, Chief Legal Officer

Operating MetricsView all

Facility Space, sq. ft.

178.5K
17.4%

FY, 2022

Products

6

FY, 2022

Facility Space Leased, sq. ft.

178.5K

FY, 2022

LocationsView all

4 locations detected

  • Mason, OH HQ

    United States

    7555 Innovation Way

  • Minnetonka, MN

    United States

    130 Cheshire Ln #250

  • Pleasanton, CA

    United States

    3875 Hopyard Rd # 160

  • Amsterdam, NH

    Netherlands

    De Entree 260

AtriCure Financials

Summary Financials

Revenue (Q2, 2024)
$116.3M
Gross profit (Q2, 2024)
$86.8M
Net income (Q2, 2024)
($8.0M)
Cash (Q2, 2024)
$106.0M
EBIT (Q2, 2024)
($7.2M)
Enterprise value
$1.4B

Footer menu